AVTR

Avantor
D

AVTR

16.930
USD
-0.36
(-2.08%)
Market Closed
Volume
0
EPS
1
Div Yield
-
P/E
16
Market Cap
11,527,680,544
Signals
هشام منسي
هشام منسي
6 months ago
buy
AVTR
AVTR@26.465
2024-09-11 13:27
AVTR@26.465 Chart
Profit
-207.75
More
Related Instruments
ABBV
ABBV
-3.090
(-1.43%)
213.580 USD
AMGN
AMGN
-8.51
(-2.60%)
318.71 USD
BMY
BMY
-1.640
(-2.60%)
61.500 USD
GSK
GSK
-0.800
(-1.98%)
39.510 USD
JNJ
JNJ
-1.855
(-1.11%)
165.845 USD
LLY
LLY
-6.36
(-0.77%)
823.59 USD
MRK
MRK
-0.530
(-0.56%)
94.710 USD
NVS
NVS
-4.050
(-3.51%)
111.450 USD
PFE
PFE
-0.675
(-2.53%)
25.985 USD
REGN
REGN
-27.40
(-3.68%)
717.41 USD
SNY
SNY
-0.590
(-0.99%)
58.770 USD
TEVA
TEVA
1.425
(9.71%)
16.105 USD
More
News

Title: Avantor

Sector: Healthcare
Industry: Medical Instruments & Supplies
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, andAMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.